Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adam Grossman Insider Profile
18 Followers
Adam Grossman, President & CEO, Director at ADMA Biologics, holds 3.71M shares in ADMA Biologics (Ticker: ADMA). Most recently, Adam Grossman Sold $48,967 shares of ADMA Biologics on Nov 22, 2024 for an estimated value of 1.03M.
Adam Grossman ADMA Biologics (ADMA)President & CEO, Director
ADMA Biologics (ADMA)
President & CEO, Director
Ranked #97,257 out of 100,202 Corporate Insiders
Profitable Transactions
4 out of 22 Profitable Transactions
Average Return
-43.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Adam Grossman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Adam Grossman
Adam Grossman's Trading History
List of latest transactions for each holding click on a transaction to see Adam Grossman's performance on stock
You May Also Like
Adam Grossman insider profile FAQ
What is the percentage of profitable transactions made by Adam Grossman?
The percentage of profitable transactions made by Adam Grossman is 18%.
What is the average return per transaction made by Adam Grossman?
The average return per transaction made by Adam Grossman is -43.50%.
What stocks does Adam Grossman hold?
Adam Grossman holds: ADMA stocks.
What was Adam Grossman’s latest transaction?
Adam Grossman latest transaction was an Informative Sell of $1.03M.
What was Adam Grossman's most profitable transaction?
Adam Grossman’s most profitable transaction was an Informative Buy of ADMA stock on October 26, 2021. The return on the trade was 108.10%.
What is Adam Grossman's role in ADMA Biologics?
Adam Grossman's role in ADMA Biologics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.